Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
QuantrolOx gives hardware teams tools to industrialize quantum hardware, and institutions means to train the workforce the industry needs.
OMass Therapeutics is a drug discovery company exploiting novel mass spectrometry platforms to develop therapeutics.
Salience Labs develops optical networking technology using silicon photonics, electronics, and machine learning.
Sensible Biotechnologies is a biotechnology company that develops cell-based technologies for the design of mRNA therapeutics.
ReEmerge is a medical technology company that specializes in cognitive network restoration therapy.
MCatalysis is a deep tech startup developing microwave catalysis technology to convert waste carbon resources.
Vivid Dx is a diagnostics company that focuses on pathogen detection and antimicrobial resistance testing services.
MoA Technology is an agricultural biotech firm that develops safe and effective herbicides, ensuring sustainable weed control solutions.
Covatic is the use of mobile based algorithms to bring smart personalisation to apps.
RQ Bio is a biotechnology company that develops medicine based on potent broad-spectrum mAbs to provide immunity to viral infections.
Applied Atomics is a european aerospace and defense company that develops space-based transportation network.
BibliU provides colleges and universities with digital content management, automation, and an analytics platform.
Caudal Energy develops bio-inspired tidal energy systems delivering predictable, low-impact renewable power from ocean currents.
Re‑Aim Therapeutics is a biotech start‑up developing functional cures for T cell–mediated autoimmune diseases.
Quantum Motion develops quantum computing systems based on silicon semiconductor technology used in conventional electronics manufacturing.
Endlyz Therapeutics is developing disease-modifying therapeutics for Parkinson’s disease (PD) and other dementias.
First Light Fusion is an energy company that focuses on researching energy generation by inertial confinement fusion.
Ascension develops geothermal-based technologies for critical mineral recovery.
Archangel Lightworks builds deployable laser communication systems for the space-enabled networks of the future.
FluoRok is revolutionizing the way fluorochemicals are produced globally.
Theolytics is a clinical stage biotechnology company developing next-generation viral therapies.
Fractile is building chips that remove every bottleneck to running large language models at a global scale
Allos is a solution to prognose, monitor, and treat autoimmune conditions.
Beacon Therapeutics is a biotechnology company that develops treatments to preserve and restore vision for rare and prevalent eye diseases.
Oxford Science Enterprises has invested in 138 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Oxford Science Enterprises's top investment sectors include Biotechnology, Artificial Intelligence (AI), Software, Medical, Therapeutics. The firm invests across 46 different industry categories.
Among tracked funding rounds, OMass Therapeutics received $310.0M in a Series C round. Oxford Science Enterprises's total known invested capital is $3.3B.
Oxford Science Enterprises's average investment size is $23.9M across its portfolio of 138 companies.
Recent Oxford Science Enterprises portfolio additions include Quantrol Ox, OMass Therapeutics, Salience Labs, Sensible Biotechnologies, ReEmerge. These companies were founded in 2020 or later.